American Thoracic Society Documents An Official American Thoracic Society/European Respiratory Society Statement: The Role of the Pulmonologist in the Diagnosis and Management of Lung Cancer

on the Role of the Pulmonologist in the Management of Lung Background : Lung cancer is a common problem seen by pulmonolo- The American Thoracic (ATS) and Society (ERS) are professional organizations whose memberships are composed of large numbers of pulmonologists. Purpose : This document describes the key role of pulmonologists in the prevention, early diagnosis, and management of lung cancer. Methods : A committee of ATS and ERS leaders and their oncology groups discussed the activities of pulmonologists in relation to lung cancer in various settings and reviewed available literature on the topic. The content of this statement was approved by the board of directors of both the ATS and ERS. Results :Optimallungcancercarerequiresamultidisciplinaryteamof specialists who care for a significant number of patientson a regular basis.Pulmonologists are responsiblefor and involved withpatients from their initial diagnosis and staging through treatment and restaging. They are often involved with complications, palliative care, and end-of-life care, and thus have an important role in team leadership. Conclusions : Lung cancer is a disease with high mortality, profound effects on the quality of the lives of patients

[1]  C. Powell,et al.  Update in lung cancer and mesothelioma 2012. , 2013, American journal of respiratory and critical care medicine.

[2]  D. Addrizzo-Harris,et al.  Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[3]  W. Bulman,et al.  Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy. , 2012, American journal of respiratory and critical care medicine.

[4]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[5]  H. Sitter,et al.  Hohe qualitative Variabilität bei nationalen und internationalen Leitlinien (LL) zur Behandlung des Lungenkarzinoms (LC) – systematische Bestandsaufnahme und methodischer Vergleich durch die European Initiative for Quality Management in Lung Cancer Care (EIQMLCC) , 2012 .

[6]  A. Nakagawara,et al.  Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. , 2011, Chest.

[7]  Jame Abraham,et al.  Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .

[8]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[9]  N. Schönfeld,et al.  Lungenkrebs in Deutschland – zur Versorgungslage der Nation , 2011 .

[10]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2011. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Nick Sevdalis,et al.  Quality of Care Management Decisions by Multidisciplinary Cancer Teams: A Systematic Review , 2011, Annals of Surgical Oncology.

[12]  W. Travis,et al.  Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  H. Kauczor,et al.  Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer , 2010, Pneumologie.

[14]  J. Vansteenkiste,et al.  Thoracic oncology in Europe: the ERS action plan by the Thoracic Oncology Assembly , 2010, European Respiratory Journal.

[15]  M. Soda,et al.  Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  M. Soda,et al.  EML4-ALK Fusion Gene Assessment Using Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration , 2010, Clinical Cancer Research.

[17]  C. Powell,et al.  Molecular Testing in Lung Cancer: The Time Is Now , 2010, Current oncology reports.

[18]  R. Freeman,et al.  The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  Ahmedin Jemal,et al.  Declining Death Rates Reflect Progress against Cancer , 2010, PloS one.

[20]  M. Kris,et al.  Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Loddenkemper,et al.  [100 years DGP -100 years of pneumology in Germany]. , 2010, Pneumologie.

[22]  S. Digumarthy,et al.  Staging of non-small cell lung cancer using integrated PET/CT. , 2009, AJR. American journal of roentgenology.

[23]  F. Galateau-Sallé,et al.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma , 2009, European Respiratory Journal.

[24]  L. Goldman,et al.  ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) , 2009, European Respiratory Journal.

[25]  P. Shah,et al.  Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis , 2009, Thorax.

[26]  Moon Soo Kim,et al.  Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. , 2009, Chest.

[27]  P. Kopinski,et al.  Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  M. Noppen,et al.  Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study , 2007, The Lancet.

[29]  M. Krasnik,et al.  Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum , 2006, European Respiratory Journal.

[30]  J Strausz,et al.  Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents , 2006, European Respiratory Journal.

[31]  James L Mulshine,et al.  Lung cancer screening. , 2005, The oncologist.

[32]  C. McArdle,et al.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer , 2005, British Journal of Cancer.

[33]  J. Coebergh,et al.  Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. , 2005, Critical reviews in oncology/hematology.

[34]  R. Govindan,et al.  Differential prognostic impact of comorbidity. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  S. Spiro,et al.  Update on lung cancer and mesothelioma. , 1999, Journal of the Royal College of Physicians of London.

[36]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.